Total serum IgE level in COPD exacerbations
The Journal of Community Health Management · 28.10.2020 · 7 (3) · 95-99
DOI: 10.18231/j.jchm.2020.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community Health Management, online erschienen am 15.10.2020. Verfasst von Mishra J K und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: COPD
Abstract (Originalsprache)
Background
COPD exacerbations were diagnosed based on the clinical parameters only. Till now we were unable to find out a reliable blood based biomarker. Serum IgE is one of the measurements of airway inflammation which is well established in asthma, it’s role in COPD not studied adequately. Materials and Methods: This is a cross sectional study conducted in a tertiary care center. This study included 75 COPD patients who were admitted in our hospital for exacerbations. Exacerbations defined by the GOLD report 2018. Complete history & Total serum IgE levels were obtained from all patients during admission, pulmonary function test has been done at the time of discharge and results were analyzed.
Results
In our study the mean value of serum IgE is 416.75 IU/L. Patients who had elevated serum IgE (>100 IU/L) levels were 55 (73.3%). FEV1/FVC ratio significantly high in elevated IgE group (0.580.09 in elevated IgE vs 0.490.10 in IgE not elevated, p more in elevated IgE group (13.7%+185ml in elevated IgE vs 6.4%+73ml in IgE not elevated, p=0.001). IgE elevated patients have seasonal variation history, Biomass exposure history. They had more Asthma COPD Overlap features than IgE not elevated group (p=0.001).
Conclusion
COPD patients can have elevated serum IgE levels during exacerbations. IgE may play an important role in pathogenesis of COPD and can be used as a biomarker for COPD Exacerbations. Key message: Serum total IgE can be used as a biomarker in COPD exacerbations. This can be used as a new therapeutic target for the same. Keywords: Humans, Chronic obstructive pulmonary, Disease, Biomarkers, Immunoglobulin E, Asthma.
Zitieren
APA
K, M. J., Thiru, A., N, S. G., Gupta, P., & Rajak, B. K. (2020). Total serum IgE level in COPD exacerbations. The Journal of Community Health Management, 7(3), 95-99. https://doi.org/10.18231/j.jchm.2020.022
Vancouver
K MJ, Thiru A, N SG, Gupta P, Rajak BK. Total serum IgE level in COPD exacerbations. The Journal of Community Health Management. 2020;7(3):95-99. doi:10.18231/j.jchm.2020.022
BibTeX
@article{K2020,
author = {K, Mishra J and Thiru, Anbarasan and N, Srivastava G and Gupta, Pulkit and Rajak, Bhupendra Kumar},
title = {Total serum IgE level in COPD exacerbations},
journal = {The Journal of Community Health Management},
year = {2020},
volume = {7},
number = {3},
pages = {95--99},
doi = {10.18231/j.jchm.2020.022}
}
EUVIMED